After the pandemic: what were the lessons learnt for pharmacovigilance? Find out in the latest episode of the Drug Safety Matters podcast.


COVID-19 forced pharmacovigilance experts to revisit their processes to deal with unprecedented volumes of data and catch unexpected safety issues.

Elena Rocca of Oslo Metropolitan University joins Drug Safety Matters host Federica Santoro in the studio for a philosophical inquiry into the lessons to be learnt from the pandemic – and what it can teach us about the science of drug safety.

Subscribe by visiting the Drug Safety Matters website or listen in right here:

You may also like


Rethinking medical device safety part 1 – new podcast episode

Medical devices are everywhere, but monitoring their safety is complex. Omar Aimer discusses the unique challenges of device pharmacovigilance and what needs to change.

29 January 2026

Patient perspectives in PV at the ISoP Mid-Year Symposium – New podcast episode

Patient engagement was a hot topic at the fireside chat held during this year’s ISoP mid-year symposium.

24 June 2025

ISoP 2025 Cairo: A Global Perspective on the Evolution and Future of Pharmacovigilance

Over 500 attendees from 80+ countries met in Cairo at ISoP 2025, reflecting on pharmacovigilance progress and shaping strategies for its future.

10 December 2025